# CNBX (Cnbx Pharmaceuticals Inc.) - SEC EDGAR Financial Statements

> Cnbx Pharmaceuticals Inc. reported $0 in revenue and a net loss of $462K for the trailing twelve months ended May 31, 2026 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/CNBX
- Markdown: https://convexityos.com/fundamentals/CNBX.md
- SEC CIK: 0001343009
- Reporting currency: USD
- Latest filing period: May 31, 2026
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001343009&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | -100.0% YoY |
| Operating Income | TTM | -$429K | Operating profit |
| Net Income | TTM | -$462K | GAAP bottom line |
| Diluted EPS | TTM | -$0.00 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | May 31, 2026 | $9.5K | Total debt: $120K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $130K | $410K | $30K | $0 | $7.2K | $9.8K | $9.6K | $5.7K | $112K |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | -- | $5.7K | $112K |
| Research & Development | $0 | $195K | $432K | $1.18M | $1.77M | $1.68M | $1.54M | $1.00M | $247K | $178K |
| Selling, General & Admin | -- | -- | -- | -- | $849K | $1.37M | $1.77M | $2.81M | $1.61M | $216K |
| Total Operating Expenses | $272K | $713K | $1.34M | $2.98M | $2.60M | $3.05M | $3.31M | $3.82M | $1.86M | $393K |
| **Operating Income** | -$272K | -$583K | -$931K | -$2.95M | -$2.60M | -$3.04M | -$3.30M | -$3.81M | -$1.85M | -$281K |
| **EBITDA** | -$272K | -$511K | -$769K | -$2.76M | -$2.38M | -$2.83M | -$3.11M | -$3.72M | -$1.85M | -$279K |
| Interest Expense | $40K | -- | -- | -- | -- | -- | -- | $852 | $4.4K | $7.2K |
| **Net Income** | -$314K | -$695K | -$3.71M | -$3.72M | -$3.19M | -$7.47M | $1.13M | -$3.78M | -$1.93M | -$307K |
| Basic EPS | $0.00 | -$0.02 | -$0.42 | -$3.59 | -$2.41 | -$12.05 | $2.41 | -$3.73 | -$2.17 | $0.00 |
| **Diluted EPS** | $0.00 | -$0.02 | -$0.42 | -$3.59 | -$2.41 | -$12.05 | $2.41 | -$3.73 | -$2.17 | $0.00 |
| Basic Shares Outstanding | 90.6M | 30.2M | 8.8M | 1.2M | 1.1M | 1.1M | 1.1M | 999.1K | 916.2K | 857.0K |
| Diluted Shares Outstanding | 90.6M | 30.2M | 8.8M | 1.2M | 1.1M | 1.1M | 1.1M | 999.1K | 916.2K | 857.0K |

### Income Statement (Quarterly)

| Line Item | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | -- | -- | $0 | $0 | -- | -- |
| **Gross Profit** | $0 | $0 | -- | -- | $0 | $0 | -- | -- |
| Research & Development | -- | $0 | $0 | $0 | $0 | $0 | $0 | -$74K |
| Total Operating Expenses | $163K | $73K | $64K | $130K | $40K | $65K | $37K | $53K |
| **Operating Income** | -$163K | -$73K | -$64K | -$130K | -$40K | -$65K | -$37K | -$53K |
| **EBITDA** | -- | -- | -$64K | -$130K | -$40K | -$65K | -$37K | -$53K |
| Interest Expense | -- | -$33K | $46K | $18K | $14K | $4.2K | $3.1K | -- |
| **Net Income** | -$154K | -$44K | -$114K | -$150K | -$60K | -$70K | -$34K | -$61K |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | -$0.00 | -- |
| **Diluted EPS** | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | -$0.00 | -- |
| Basic Shares Outstanding | 1.32B | 931.0M | 732.9M | -- | 42.6M | 32.1M | 31.1M | -- |
| Diluted Shares Outstanding | 1.32B | 931.0M | 732.9M | -- | 42.6M | 32.1M | 31.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $15K | $26K | $130K | $118K | $1.39M | $778K | $266K | $1.39M | $1.39M | $19K |
| Short-Term Investments | -- | -- | -- | -- | -- | $0 | $3.26M | $0 | -- | -- |
| **Cash & Short-Term Investments** | $15K | $26K | $130K | $118K | $1.39M | $778K | $3.52M | $1.39M | $1.39M | $19K |
| **Total Current Assets** | $18K | $31K | $224K | $198K | $1.59M | $930K | $4.31M | $1.62M | $3.52M | $22K |
| Property, Plant & Equipment, Net | $0 | $0 | $275K | $437K | $643K | $863K | $1.00M | $974K | $120K | $1.6K |
| **Total Non-Current Assets** | $0 | $0 | $275K | $613K | $1.49M | $1.29M | $10.88M | $1.56M | $120K | $1.6K |
| **Total Assets** | $18K | $31K | $499K | $811K | $3.08M | $2.22M | $15.18M | $3.18M | $3.64M | $24K |
| Short-Term Debt | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $2.51M | $2.51M | $2.52M | $2.44M | $1.27M | $455K | $439K | $539K | $699K | $491K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | -- | $0 | $0 | $0 | $0 | $5.88M | $0 |
| **Total Liabilities** | $2.51M | $2.51M | $2.52M | -- | $1.27M | $455K | $439K | $539K | $6.58M | $491K |
| **Total Debt (incl. Leases)** | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Common Stock | $55K | $3.1K | $2.3K | $124 | $14K | $14K | $13K | $12K | $12K | $11K |
| Retained Earnings | -$25.27M | -$24.95M | -$24.26M | -$20.55M | -$16.83M | -$13.63M | -$6.16M | -$7.30M | -$3.52M | -$1.59M |
| Accumulated Other Comp. Income | $0 | $0 | $0 | -$2.57M | -$1.91M | -$2.77M | $2.81M | $0 | -- | -- |
| **Total Stockholders' Equity** | -$2.50M | -$2.48M | -$2.02M | $1.63M | $1.81M | $1.76M | $14.74M | $2.65M | -$2.94M | -$467K |
| Total Equity | -$2.50M | -$2.48M | -$2.02M | $1.63M | $1.81M | $1.76M | $14.74M | $2.65M | -$2.94M | -$467K |

### Balance Sheet (Quarterly)

| Line Item | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $9.5K | $12K | $7.7K | $15K | $14K | $46K | $17K | $26K |
| **Cash & Short-Term Investments** | $9.5K | $12K | $7.7K | $15K | $14K | $46K | $17K | $26K |
| **Total Current Assets** | $13K | $15K | $11K | $18K | $19K | $51K | $22K | $31K |
| Property, Plant & Equipment, Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $13K | $15K | $11K | $18K | $19K | $51K | $22K | $31K |
| Short-Term Debt | $120K | $75K | -- | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $2.67M | $2.55M | $2.58M | $2.51M | $2.56M | $2.62M | $2.54M | $2.51M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $2.67M | $2.55M | $2.58M | $2.51M | $2.56M | $2.62M | $2.54M | $2.51M |
| **Total Debt (incl. Leases)** | $120K | $75K | -- | $0 | -- | -- | -- | -- |
| Common Stock | $148K | $113K | $75K | $55K | $9.3K | $3.4K | $3.1K | $3.1K |
| Retained Earnings | -$25.58M | -$25.43M | -$25.38M | -$25.27M | -$25.12M | -$25.06M | -$24.99M | -$24.95M |
| Accumulated Other Comp. Income | $0 | $0 | -- | $0 | -- | $0 | -- | $0 |
| **Total Stockholders' Equity** | -$2.66M | -$2.53M | -$2.57M | -$2.50M | -$2.54M | -$2.57M | -$2.51M | -$2.48M |
| Total Equity | -$2.66M | -$2.53M | -$2.57M | -$2.50M | -$2.54M | -$2.57M | -$2.51M | -$2.48M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$314K | -$695K | -$3.71M | -$3.72M | -$3.19M | -$7.47M | $4.36M | $0 | -$1.93M | -$307K |
| Depreciation & Amortization | $0 | $72K | $162K | $199K | $221K | $215K | $189K | $88K | $7.0K | $1.6K |
| Stock-Based Compensation | $0 | $140K | $180K | $729K | $0 | $72K | $247K | $1.85M | $881K | $30K |
| **Operating Cash Flow** | -$171K | -$244K | -$113K | -$1.68M | -$2.49M | -$2.77M | -$3.09M | -$1.97M | -$864K | -$120K |
| **Investing Cash Flow** | $0 | $113K | $25K | $25K | $645K | $3.29M | -$5.25M | -$1.44M | -$126K | $0 |
| Common Stock Issued | -- | -- | -- | -- | -- | $0 | $7.29M | $1.55M | $4.41M | $94K |
| **Financing Cash Flow** | $160K | $28K | $100K | $390K | $2.46M | $0 | $7.22M | $1.44M | $4.34M | $114K |
| **Net Change in Cash** | -$11K | -$103K | $12K | -$1.26M | $609K | $512K | -$1.13M | -$1.97M | $3.35M | -$6.1K |

### Cash Flow Statement (Quarterly)

| Line Item | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$154K | -$44K | -$114K | -$150K | -$60K | -$70K | -$34K | -$61K |
| Depreciation & Amortization | -- | -- | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | -- | -- | $0 | $0 | $0 | $0 | $0 | $35K |
| **Operating Cash Flow** | -$48K | -$31K | -$47K | -$29K | -$52K | -$52K | -$39K | -$48K |
| **Investing Cash Flow** | -- | -- | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $30K | -- |
| **Financing Cash Flow** | $45K | $35K | $40K | $30K | $20K | $80K | $30K | $1.3K |
| **Net Change in Cash** | -$2.7K | $4.5K | -$7.4K | -- | -$32K | $28K | -$9.1K | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | -- | 100.0% | 100.0% |
| **Operating Margin** | -- | -448.3% | -227.1% | -9860.4% | -- | -42524.1% | -33563.0% | -39670.1% | -32616.1% | -249.5% |
| **Net Profit Margin** | -- | -534.5% | -904.6% | -12428.2% | -- | -104337.9% | 11510.4% | -39335.7% | -34022.5% | -273.0% |
| Return on Equity (ROE) | -- | -- | -- | -228.1% | -176.9% | -423.2% | 7.7% | -142.8% | -- | -- |
| Return on Assets (ROA) | -1703.0% | -2215.2% | -743.5% | -459.0% | -103.8% | -336.5% | 7.5% | -118.6% | -53.2% | -1295.2% |
| Current Ratio | 0.01x | 0.01x | 0.09x | 0.08x | 1.25x | 2.04x | 9.81x | 3.01x | 5.03x | 0.04x |
| Quick Ratio | 0.01x | 0.01x | 0.05x | 0.05x | 1.09x | 1.71x | 8.03x | 2.58x | 1.99x | 0.04x |
| **Revenue Growth (YoY)** | -100.0% | -68.3% | +1269.1% | -- | -100.0% | -27.3% | +2.5% | +68.9% | -94.9% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -94.9% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -759.1% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -600.0% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -100.0% | -52.0% | +383.7% | +294.9% | -100.0% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -102.2% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -1102.6% | -448.3% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -1356.0% | -534.5% |
| Return on Assets (ROA) | -3611.5% | -2467.6% | -3523.9% | -1703.0% | -1205.8% | -583.0% | -2470.1% | -2215.2% |
| Current Ratio | 0.00x | 0.01x | 0.00x | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.02x | 0.01x | 0.01x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -100.0% | -100.0% | -100.0% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -100.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -23219.6% | -- | -- | -335.2% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
